3[2]Eichhoff TC. Antibiotics and nosocomial infections. In: Bennet JV and Branchman PS eds:Hospital Infections. 4th ed, Lippincott-Raven,Philadelphia; 1998,201
4[3]Pavia M, Bianco A and Viggiani NMA et al. Prevalence of hospital infection-acquired infections in Italy. J Hosp Infect ,2000,44(2): 135-139
5[4]Vaque J,Rossello J and Arribas L.Prevalence of nosocomial infections in Spain:EPINE study 1990-1997. J Hosp Infect1999,43(Supple):S 105-S 111
6[5]Esen S,Leblebicioglu H.Prevallence of nosocomial infections a intensive care units in Turkey:a multicentre 1-day point prevalence study.Scand InfectDis 2004, 36(2):144-148
7[6]Dampis U,Baloe A,Vigante D,et al.Prevallence of nosocomial infection in two Lativan hospitals.http://www.eurosurveillance.org/em/vo8no3/o8o3-223.asp
8[7]Levy SB. Multidryg resistance-A sign of the times. N Eng J Med ,1998, 38(19):1336-1338
9[8]Tenover FC. Development and spread of bacterial resistance to antimicrobial agent:anoverview.CID 2001,33(Supply 3):S108-115
10[9]Centers for Disease Control and Prevention.Vancomycin-resistant Staphylococcus aureusNew York, 2004. MMWR.2004, 53(15):322-323.
